Editorial: Advanced neural stem cell therapies for spinal cord injury

Venkatesh Katari; Santhosh Kumar Pasupuleti; Madhubanti Mullick; Vinod Kumar Reddy Lekkala; Dwaipayan Sen

doi:10.3389/fphar.2024.1469535

Editorial: Advanced neural stem cell therapies for spinal cord injury

Front Pharmacol. 2024 Aug 6:15:1469535. doi: 10.3389/fphar.2024.1469535. eCollection 2024.

Authors

Venkatesh Katari¹, Santhosh Kumar Pasupuleti², Madhubanti Mullick³, Vinod Kumar Reddy Lekkala⁴, Dwaipayan Sen⁵

Affiliations

¹ Department of Physiology and Pharmacology, College of Medicine and Life Sciences, The University of Toledo, Toledo, OH, United States.
² Department of Pediatrics, Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN, United States.
³ Department of Cellular and Molecular Medicine, University of California, San Diego, San Diego, CA, United States.
⁴ Department of Ophthalmology, University of California, San Francisco, San Francisco, CA, United States.
⁵ Cell And Gene Therapies, Innovative Medicines Accelerator (IMA), Stanford University, Palo Alto, CA, United States.

No abstract available

Keywords: 3D scaffolds; Mesenchymal stem cells; neural regeneration; neural stem cells; spinal cord injury.

Publication types

Editorial

Grants and funding

The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This research topic is part of National Post Doctoral Fellowship (NPDF) (File No: PDF/2016/003652/LS) project sanctioned from Science and Engineering Research Board (SERB), Department of Science and Technology (DST), India to VK (PI) and DS (mentor).